Table 1.

Clinical Features and Genetic Results of Children With Severe FSS Examined by WES

Patient No.SexAge, yPatient`s Height (SDS)Shorter Parent`s Height (SDS)IGF-1 (SDS)Stimulated GH, μg/LBirth Weight (SDS)Birth Length (SDS)Additional Phenotypic FeaturesGeneMutation StatusTranscript VariantProtein VariantParents Available for Genetic TestingConclusion
SGA only – 5/8 (62.5%) with P/LP variant
1F10−4.32−3.54−1.6811.0−1.64−3.05COL11A1M/nc.2921C>Ap.Pro974GlnYesLikely pathogenic
2M14−4.10−2.89−3.6810.0−1.64−2.39Central hypothyroidismTRHRM/Mc.392T>Cp.Ile131ThrYesLikely pathogenic (16)
3M12−3.49−3.00−0.2611.5−3.01−3.87THRAM/nc.455G>Ap.Arg152GlnYesUncertain significance
4M10−3.42−3.03−0.9810.2−1.62−3.26Advanced bone age (+1.9 years)IHHM/nc.857C>Tp.Pro286LeuNoUncertain significance
5M9−3.34−2.67−0.92NA−2.13−3.52COL9A2M/nc.1834G>Ap.Gly612ArgYesBenign
6M16−3.06−2.750.1619.3−2.39−2.57ScoliosisCOL11A1M/nc.1543C>Gp.Gln515GluYesLikely pathogenic
7M10−2.92−3.30−0.6329.7−1.35−2.13IGF1RM/nc.158C>Tp.Thr53MetYesLikely pathogenic
8F11−2.76−2.75−1.04NA−2.56−4.14Frequent OMA, genua valga, advanced bone age (+3.4 y)COL2A1M1/M2c.410G>A / c.3106C>Gp.Arg137His/ p.Arg1036GlyYesLikely pathogenic (6) / Likely pathogenic
GHD only – 4/9 (44.4%) with P/LP variant
9M14−4.95−2.89−2.487.22−0.94−1.78Minor stigmata, bilateral cryptorchidismIGFALSM/nc.860C>Tp.Pro287LeuNoUncertain significance (17)
10M8−4.48−2.73−1.116.36−1.06−1.75B-cell immunity disorder, skin problems (hyperkeratosis, alopecia), corneal ulcerationMBTPS2M/-c.1538T>Cp.Leu513ProYesLikely pathogenic (19)
PIK3CDM/nc.1775T>Cp.Val952AlaYesUncertain significance
11M7−4.37−2.89−1.869.40−0.56−1.04Limb shorteningFGFR3M/nc.1612A>Gp.Ile538ValYesLikely pathogenic (18)
12F8−3.50−2.60−1.572.500.04−0.95Limb shorteningHSPG2M/nc.8044C>Tp.Arg2682TrpYesBenign
13M13−3.10−2.59−1.915.92−0.85−0.65PAX6M/nc.13C>G
c.392C>Gp.His5Asp
p.Ala131GlyYesBenign
14M5−3.06−3.86−2.188.34−1.94−1.42HMGA2M/nc.223C>Tp.Arg75TrpYesLikely pathogenic
15M9−3.04−2.75−1.826.06−1.57−1.68Minor stigmataIGFALSM/nc.589C>Tp.Arg197CysYesPathogenic
IHHM/nc.1169G>Ap.Arg390HisYesUncertain significance
16M8−2.75−2.75−1.237.79−1.02−1.35IGFALSM/nc.1195G>Ap.Gly399ArgNoUncertain significance
17M12−2.53−2.75−1.288.30−1.60−0.65GH1M/nc.478C>Tp.Arg160TrpYesBenign
FBN1M/nc.902G>Tp.Gly301ValYesBenign
SGA + GHD – 3/11 (27.3%) with P/LP variant
18M9−4.17−3.81−1.985.18−1.95−3.09Hypospadia, minor stigmataHSPG2M/nc.12874G>Ap.Glu4292LysYesBenign
19F8−3.82−4.03−0.447.77−0.84−2.14Limb shorteningGLI2GLI2M/nc.4332G>A
c.4333C>Tp.Met1444Ile
p.Leu1445PheYesBenign
20M6−3.61−3.25−1.146.4−2.16−3.12No variant found
21M14−3.47−2.89−1.638.39−2.39−3.00MicrocephalyCOL2A1M/nc.3106C>Gp.Arg1036GlyYesLikely pathogenic
22M8−3.28−2.89−1.836.37−0.60−2.39No variant found
23M13−3.26−2.81−1.227.44−2.18−2.22SHHM/nc.424G>Ap.Glu142LysYesBenign
24F14−3.18−2.75−2.17.15−2.56−3.13Lower-limb shortening, minor stigmataGHSRM/nc.526G>Ap.Gly176ArgYesPathogenic
25M8−2.84−2.87−0.985.91−2.59−2.83Minor stigmataCOL10A1M/nc.1581G>Cp.Lys527AsnYesLikely benign
26F12−2.76−2.89−3.453.62−2.78−1.23Shorter trunk, longer limbs, blue sclera, teeth decay, ectopic posterior pituitaryNo variant found
27M10−2.70−2.75−0.663.44−2.39−3.43EXT2M/nc.2034G>Cp.Lys678AsnNoUncertain significance
28M5−2.62−3.60−2.256.99−1.40−2.22FLNBM/nc.1601T>Gp.Ile534SerYesLikely pathogenic
Patient No.SexAge, yPatient`s Height (SDS)Shorter Parent`s Height (SDS)IGF-1 (SDS)Stimulated GH, μg/LBirth Weight (SDS)Birth Length (SDS)Additional Phenotypic FeaturesGeneMutation StatusTranscript VariantProtein VariantParents Available for Genetic TestingConclusion
SGA only – 5/8 (62.5%) with P/LP variant
1F10−4.32−3.54−1.6811.0−1.64−3.05COL11A1M/nc.2921C>Ap.Pro974GlnYesLikely pathogenic
2M14−4.10−2.89−3.6810.0−1.64−2.39Central hypothyroidismTRHRM/Mc.392T>Cp.Ile131ThrYesLikely pathogenic (16)
3M12−3.49−3.00−0.2611.5−3.01−3.87THRAM/nc.455G>Ap.Arg152GlnYesUncertain significance
4M10−3.42−3.03−0.9810.2−1.62−3.26Advanced bone age (+1.9 years)IHHM/nc.857C>Tp.Pro286LeuNoUncertain significance
5M9−3.34−2.67−0.92NA−2.13−3.52COL9A2M/nc.1834G>Ap.Gly612ArgYesBenign
6M16−3.06−2.750.1619.3−2.39−2.57ScoliosisCOL11A1M/nc.1543C>Gp.Gln515GluYesLikely pathogenic
7M10−2.92−3.30−0.6329.7−1.35−2.13IGF1RM/nc.158C>Tp.Thr53MetYesLikely pathogenic
8F11−2.76−2.75−1.04NA−2.56−4.14Frequent OMA, genua valga, advanced bone age (+3.4 y)COL2A1M1/M2c.410G>A / c.3106C>Gp.Arg137His/ p.Arg1036GlyYesLikely pathogenic (6) / Likely pathogenic
GHD only – 4/9 (44.4%) with P/LP variant
9M14−4.95−2.89−2.487.22−0.94−1.78Minor stigmata, bilateral cryptorchidismIGFALSM/nc.860C>Tp.Pro287LeuNoUncertain significance (17)
10M8−4.48−2.73−1.116.36−1.06−1.75B-cell immunity disorder, skin problems (hyperkeratosis, alopecia), corneal ulcerationMBTPS2M/-c.1538T>Cp.Leu513ProYesLikely pathogenic (19)
PIK3CDM/nc.1775T>Cp.Val952AlaYesUncertain significance
11M7−4.37−2.89−1.869.40−0.56−1.04Limb shorteningFGFR3M/nc.1612A>Gp.Ile538ValYesLikely pathogenic (18)
12F8−3.50−2.60−1.572.500.04−0.95Limb shorteningHSPG2M/nc.8044C>Tp.Arg2682TrpYesBenign
13M13−3.10−2.59−1.915.92−0.85−0.65PAX6M/nc.13C>G
c.392C>Gp.His5Asp
p.Ala131GlyYesBenign
14M5−3.06−3.86−2.188.34−1.94−1.42HMGA2M/nc.223C>Tp.Arg75TrpYesLikely pathogenic
15M9−3.04−2.75−1.826.06−1.57−1.68Minor stigmataIGFALSM/nc.589C>Tp.Arg197CysYesPathogenic
IHHM/nc.1169G>Ap.Arg390HisYesUncertain significance
16M8−2.75−2.75−1.237.79−1.02−1.35IGFALSM/nc.1195G>Ap.Gly399ArgNoUncertain significance
17M12−2.53−2.75−1.288.30−1.60−0.65GH1M/nc.478C>Tp.Arg160TrpYesBenign
FBN1M/nc.902G>Tp.Gly301ValYesBenign
SGA + GHD – 3/11 (27.3%) with P/LP variant
18M9−4.17−3.81−1.985.18−1.95−3.09Hypospadia, minor stigmataHSPG2M/nc.12874G>Ap.Glu4292LysYesBenign
19F8−3.82−4.03−0.447.77−0.84−2.14Limb shorteningGLI2GLI2M/nc.4332G>A
c.4333C>Tp.Met1444Ile
p.Leu1445PheYesBenign
20M6−3.61−3.25−1.146.4−2.16−3.12No variant found
21M14−3.47−2.89−1.638.39−2.39−3.00MicrocephalyCOL2A1M/nc.3106C>Gp.Arg1036GlyYesLikely pathogenic
22M8−3.28−2.89−1.836.37−0.60−2.39No variant found
23M13−3.26−2.81−1.227.44−2.18−2.22SHHM/nc.424G>Ap.Glu142LysYesBenign
24F14−3.18−2.75−2.17.15−2.56−3.13Lower-limb shortening, minor stigmataGHSRM/nc.526G>Ap.Gly176ArgYesPathogenic
25M8−2.84−2.87−0.985.91−2.59−2.83Minor stigmataCOL10A1M/nc.1581G>Cp.Lys527AsnYesLikely benign
26F12−2.76−2.89−3.453.62−2.78−1.23Shorter trunk, longer limbs, blue sclera, teeth decay, ectopic posterior pituitaryNo variant found
27M10−2.70−2.75−0.663.44−2.39−3.43EXT2M/nc.2034G>Cp.Lys678AsnNoUncertain significance
28M5−2.62−3.60−2.256.99−1.40−2.22FLNBM/nc.1601T>Gp.Ile534SerYesLikely pathogenic

Abbreviations: F, female; GHD, GH deficiency; LP, likely pathogenic; M, male; M/n, heterozygote; M/M, homozygote; M1/M2, compound heterozygote; M/-, hemizygote; OMA, otitis media acuta; P, pathogenic; SDS, SD score; SGA, small for gestational age.

Table 1.

Clinical Features and Genetic Results of Children With Severe FSS Examined by WES

Patient No.SexAge, yPatient`s Height (SDS)Shorter Parent`s Height (SDS)IGF-1 (SDS)Stimulated GH, μg/LBirth Weight (SDS)Birth Length (SDS)Additional Phenotypic FeaturesGeneMutation StatusTranscript VariantProtein VariantParents Available for Genetic TestingConclusion
SGA only – 5/8 (62.5%) with P/LP variant
1F10−4.32−3.54−1.6811.0−1.64−3.05COL11A1M/nc.2921C>Ap.Pro974GlnYesLikely pathogenic
2M14−4.10−2.89−3.6810.0−1.64−2.39Central hypothyroidismTRHRM/Mc.392T>Cp.Ile131ThrYesLikely pathogenic (16)
3M12−3.49−3.00−0.2611.5−3.01−3.87THRAM/nc.455G>Ap.Arg152GlnYesUncertain significance
4M10−3.42−3.03−0.9810.2−1.62−3.26Advanced bone age (+1.9 years)IHHM/nc.857C>Tp.Pro286LeuNoUncertain significance
5M9−3.34−2.67−0.92NA−2.13−3.52COL9A2M/nc.1834G>Ap.Gly612ArgYesBenign
6M16−3.06−2.750.1619.3−2.39−2.57ScoliosisCOL11A1M/nc.1543C>Gp.Gln515GluYesLikely pathogenic
7M10−2.92−3.30−0.6329.7−1.35−2.13IGF1RM/nc.158C>Tp.Thr53MetYesLikely pathogenic
8F11−2.76−2.75−1.04NA−2.56−4.14Frequent OMA, genua valga, advanced bone age (+3.4 y)COL2A1M1/M2c.410G>A / c.3106C>Gp.Arg137His/ p.Arg1036GlyYesLikely pathogenic (6) / Likely pathogenic
GHD only – 4/9 (44.4%) with P/LP variant
9M14−4.95−2.89−2.487.22−0.94−1.78Minor stigmata, bilateral cryptorchidismIGFALSM/nc.860C>Tp.Pro287LeuNoUncertain significance (17)
10M8−4.48−2.73−1.116.36−1.06−1.75B-cell immunity disorder, skin problems (hyperkeratosis, alopecia), corneal ulcerationMBTPS2M/-c.1538T>Cp.Leu513ProYesLikely pathogenic (19)
PIK3CDM/nc.1775T>Cp.Val952AlaYesUncertain significance
11M7−4.37−2.89−1.869.40−0.56−1.04Limb shorteningFGFR3M/nc.1612A>Gp.Ile538ValYesLikely pathogenic (18)
12F8−3.50−2.60−1.572.500.04−0.95Limb shorteningHSPG2M/nc.8044C>Tp.Arg2682TrpYesBenign
13M13−3.10−2.59−1.915.92−0.85−0.65PAX6M/nc.13C>G
c.392C>Gp.His5Asp
p.Ala131GlyYesBenign
14M5−3.06−3.86−2.188.34−1.94−1.42HMGA2M/nc.223C>Tp.Arg75TrpYesLikely pathogenic
15M9−3.04−2.75−1.826.06−1.57−1.68Minor stigmataIGFALSM/nc.589C>Tp.Arg197CysYesPathogenic
IHHM/nc.1169G>Ap.Arg390HisYesUncertain significance
16M8−2.75−2.75−1.237.79−1.02−1.35IGFALSM/nc.1195G>Ap.Gly399ArgNoUncertain significance
17M12−2.53−2.75−1.288.30−1.60−0.65GH1M/nc.478C>Tp.Arg160TrpYesBenign
FBN1M/nc.902G>Tp.Gly301ValYesBenign
SGA + GHD – 3/11 (27.3%) with P/LP variant
18M9−4.17−3.81−1.985.18−1.95−3.09Hypospadia, minor stigmataHSPG2M/nc.12874G>Ap.Glu4292LysYesBenign
19F8−3.82−4.03−0.447.77−0.84−2.14Limb shorteningGLI2GLI2M/nc.4332G>A
c.4333C>Tp.Met1444Ile
p.Leu1445PheYesBenign
20M6−3.61−3.25−1.146.4−2.16−3.12No variant found
21M14−3.47−2.89−1.638.39−2.39−3.00MicrocephalyCOL2A1M/nc.3106C>Gp.Arg1036GlyYesLikely pathogenic
22M8−3.28−2.89−1.836.37−0.60−2.39No variant found
23M13−3.26−2.81−1.227.44−2.18−2.22SHHM/nc.424G>Ap.Glu142LysYesBenign
24F14−3.18−2.75−2.17.15−2.56−3.13Lower-limb shortening, minor stigmataGHSRM/nc.526G>Ap.Gly176ArgYesPathogenic
25M8−2.84−2.87−0.985.91−2.59−2.83Minor stigmataCOL10A1M/nc.1581G>Cp.Lys527AsnYesLikely benign
26F12−2.76−2.89−3.453.62−2.78−1.23Shorter trunk, longer limbs, blue sclera, teeth decay, ectopic posterior pituitaryNo variant found
27M10−2.70−2.75−0.663.44−2.39−3.43EXT2M/nc.2034G>Cp.Lys678AsnNoUncertain significance
28M5−2.62−3.60−2.256.99−1.40−2.22FLNBM/nc.1601T>Gp.Ile534SerYesLikely pathogenic
Patient No.SexAge, yPatient`s Height (SDS)Shorter Parent`s Height (SDS)IGF-1 (SDS)Stimulated GH, μg/LBirth Weight (SDS)Birth Length (SDS)Additional Phenotypic FeaturesGeneMutation StatusTranscript VariantProtein VariantParents Available for Genetic TestingConclusion
SGA only – 5/8 (62.5%) with P/LP variant
1F10−4.32−3.54−1.6811.0−1.64−3.05COL11A1M/nc.2921C>Ap.Pro974GlnYesLikely pathogenic
2M14−4.10−2.89−3.6810.0−1.64−2.39Central hypothyroidismTRHRM/Mc.392T>Cp.Ile131ThrYesLikely pathogenic (16)
3M12−3.49−3.00−0.2611.5−3.01−3.87THRAM/nc.455G>Ap.Arg152GlnYesUncertain significance
4M10−3.42−3.03−0.9810.2−1.62−3.26Advanced bone age (+1.9 years)IHHM/nc.857C>Tp.Pro286LeuNoUncertain significance
5M9−3.34−2.67−0.92NA−2.13−3.52COL9A2M/nc.1834G>Ap.Gly612ArgYesBenign
6M16−3.06−2.750.1619.3−2.39−2.57ScoliosisCOL11A1M/nc.1543C>Gp.Gln515GluYesLikely pathogenic
7M10−2.92−3.30−0.6329.7−1.35−2.13IGF1RM/nc.158C>Tp.Thr53MetYesLikely pathogenic
8F11−2.76−2.75−1.04NA−2.56−4.14Frequent OMA, genua valga, advanced bone age (+3.4 y)COL2A1M1/M2c.410G>A / c.3106C>Gp.Arg137His/ p.Arg1036GlyYesLikely pathogenic (6) / Likely pathogenic
GHD only – 4/9 (44.4%) with P/LP variant
9M14−4.95−2.89−2.487.22−0.94−1.78Minor stigmata, bilateral cryptorchidismIGFALSM/nc.860C>Tp.Pro287LeuNoUncertain significance (17)
10M8−4.48−2.73−1.116.36−1.06−1.75B-cell immunity disorder, skin problems (hyperkeratosis, alopecia), corneal ulcerationMBTPS2M/-c.1538T>Cp.Leu513ProYesLikely pathogenic (19)
PIK3CDM/nc.1775T>Cp.Val952AlaYesUncertain significance
11M7−4.37−2.89−1.869.40−0.56−1.04Limb shorteningFGFR3M/nc.1612A>Gp.Ile538ValYesLikely pathogenic (18)
12F8−3.50−2.60−1.572.500.04−0.95Limb shorteningHSPG2M/nc.8044C>Tp.Arg2682TrpYesBenign
13M13−3.10−2.59−1.915.92−0.85−0.65PAX6M/nc.13C>G
c.392C>Gp.His5Asp
p.Ala131GlyYesBenign
14M5−3.06−3.86−2.188.34−1.94−1.42HMGA2M/nc.223C>Tp.Arg75TrpYesLikely pathogenic
15M9−3.04−2.75−1.826.06−1.57−1.68Minor stigmataIGFALSM/nc.589C>Tp.Arg197CysYesPathogenic
IHHM/nc.1169G>Ap.Arg390HisYesUncertain significance
16M8−2.75−2.75−1.237.79−1.02−1.35IGFALSM/nc.1195G>Ap.Gly399ArgNoUncertain significance
17M12−2.53−2.75−1.288.30−1.60−0.65GH1M/nc.478C>Tp.Arg160TrpYesBenign
FBN1M/nc.902G>Tp.Gly301ValYesBenign
SGA + GHD – 3/11 (27.3%) with P/LP variant
18M9−4.17−3.81−1.985.18−1.95−3.09Hypospadia, minor stigmataHSPG2M/nc.12874G>Ap.Glu4292LysYesBenign
19F8−3.82−4.03−0.447.77−0.84−2.14Limb shorteningGLI2GLI2M/nc.4332G>A
c.4333C>Tp.Met1444Ile
p.Leu1445PheYesBenign
20M6−3.61−3.25−1.146.4−2.16−3.12No variant found
21M14−3.47−2.89−1.638.39−2.39−3.00MicrocephalyCOL2A1M/nc.3106C>Gp.Arg1036GlyYesLikely pathogenic
22M8−3.28−2.89−1.836.37−0.60−2.39No variant found
23M13−3.26−2.81−1.227.44−2.18−2.22SHHM/nc.424G>Ap.Glu142LysYesBenign
24F14−3.18−2.75−2.17.15−2.56−3.13Lower-limb shortening, minor stigmataGHSRM/nc.526G>Ap.Gly176ArgYesPathogenic
25M8−2.84−2.87−0.985.91−2.59−2.83Minor stigmataCOL10A1M/nc.1581G>Cp.Lys527AsnYesLikely benign
26F12−2.76−2.89−3.453.62−2.78−1.23Shorter trunk, longer limbs, blue sclera, teeth decay, ectopic posterior pituitaryNo variant found
27M10−2.70−2.75−0.663.44−2.39−3.43EXT2M/nc.2034G>Cp.Lys678AsnNoUncertain significance
28M5−2.62−3.60−2.256.99−1.40−2.22FLNBM/nc.1601T>Gp.Ile534SerYesLikely pathogenic

Abbreviations: F, female; GHD, GH deficiency; LP, likely pathogenic; M, male; M/n, heterozygote; M/M, homozygote; M1/M2, compound heterozygote; M/-, hemizygote; OMA, otitis media acuta; P, pathogenic; SDS, SD score; SGA, small for gestational age.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close